Deutsche Bank
ANIP icon

Deutsche Bank’s ANI Pharmaceuticals ANIP Stock Holding History

Deutsche Bank’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-650
Closed -$47K – 4979
2019
Q3 		$47K Buy
+650
New +$48.6K ﹤0.01% 3960

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank's ANIP Position: Q2 2026 in Review

Deutsche Bank increased its ANI Pharmaceuticals (ANIP) stake by 1.2% in Q2 2026, buying an estimated $302K and bringing the position to 323,443 shares worth $26.8M. The position accounts for 0.01% of the portfolio, ranked #787.

Deutsche Bank first reported a position in ANIP in Q2 2013 and has held it in 51 quarters since. The position peaked at $31M in Q4 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Deutsche Bank held 323,443 shares of ANI Pharmaceuticals worth $26.8M as of Q2 2026.
  • Deutsche Bank bought 3,768 ANI Pharmaceuticals shares in Q2 2026, an estimated $302K.
  • ANI Pharmaceuticals made up 0.01% of Deutsche Bank's portfolio in Q2 2026, its #787 holding.
  • Deutsche Bank first reported a position in ANI Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
  • Deutsche Bank's ANI Pharmaceuticals position peaked at $31M in Q4 2025.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.